Period 2 efficacy results
AHO
Of the 43 patients in the AHO population who completed period 1, all entered and 42 completed period 2. The main statistical comparisons were based on within-group comparisons for patients randomized in period 1 to placebo and crossed over to receive garetosmab in the COVID-19 mITT population (